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Abstract
Background: The Qatar Biobank aims to collect extensive lifestyle, clinical, and biological information from up to
60,000 men and women Qatari nationals and long-term residents (individuals living in the country for ≥15 years)
aged ≥18 years (approximately one-fifth of all Qatari citizens), to follow up these same individuals over the long
term to record any subsequent disease, and hence to study the causes and progression of disease, and disease
burden, in the Qatari population.
Methods: Between the 11th-December-2012 and 20th-February-2014, 1209 participants were recruited into the pilot
study of the Qatar Biobank. At recruitment, extensive phenotype information was collected from each participant,
including information/measurements of socio-demographic factors, prevalent health conditions, diet, lifestyle,
anthropometry, body composition, bone health, cognitive function, grip strength, retinal imaging, total body dual
energy X-ray absorptiometry, and measurements of cardiovascular and respiratory function. Blood, urine, and saliva
were collected and stored for future research use. A panel of 66 clinical biomarkers was routinely measured on
fresh blood samples in all participants. Rates of recruitment are to be progressively increased in the coming period
and the recruitment base widened to achieve a cohort of consented individuals broadly representative of the
eligible Qatari population. In addition, it is planned to add additional measures in sub-samples of the cohort,
including Magnetic Resonance Imaging (MRI) of the brain, heart and abdomen.
Results: The mean time for collection of the extensive phenotypic information and biological samples from each
participant at the baseline recruitment visit was 179 min. The 1209 pilot study participants (506 men and 703
women) were aged between 28–80 years (median 39 years); 899 (74.4 %) were Qatari nationals and 310 (25.6 %)
were long-term residents. Approximately two-thirds of pilot participants were educated to graduate level or above.
Conclusions: The pilot has proven that recruitment of volunteers into the Qatar Biobank project with intensive
baseline measurements of behavioural, physical, and clinical characteristics is well accepted and logistically feasible.
Qatar Biobank will provide a powerful resource to investigate the major determinants of ill-health and well-being in
Qatar, providing valuable insights into the current and future public health burden that faces the country.
Keywords: Biobank, Cohort study, Obesity, Population health, Risk factors
* Correspondence: e.riboli@imperial.ac.uk; p.elliott@imperial.ac.uk
5School of Public Health, Imperial College London, St Mary’s campus, Norfolk
Place, London, UK
Full list of author information is available at the end of the article
© 2015 Al Kuwari et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Al Kuwari et al. BMC Public Health  (2015) 15:1208 
DOI 10.1186/s12889-015-2522-7
Background
Over the past 50 years Qatar has experienced major eco-
nomic growth and demographic and socio-economic
changes. During this time the population of the country
has risen rapidly, from 369,079 in 1986 [1], to over 2.4
million in 2015 (1.9 million aged over 15 years) [2] -
most of this increase was driven by an influx of
economic migrants, and there are estimated to be
300,000 Qatari nationals (~14 % of the total population).
The population has experienced a major shift in diet
with increasing availability of western type foods, and
consequent increasing consumption of fat rich foods,
meat and meat products, refined sugar, and industrially
processed foods. In addition, similar to other high in-
come countries, food has become relatively inexpensive
compared to the average purchasing power. In parallel,
changes in the economic, industrial, and urban land-
scape have led to a substantial reduction in physical
activity, mirroring what has happened over the past de-
cades in most of the economically developed world [3].
In this societal context, obesity has become increasingly
prevalent in Qatar as it has in many countries around
the world [4]. The 2012 national STEPwise survey re-
ported that approximately 70 % of the population is over-
weight or obese (body mass index (BMI) ≥25 kg/m2) [3].
Obesity related comorbidities are now as common in
Qatar as in most neighbouring countries, with the 2012
national STEPwise survey reporting high prevalence of
hypertension (32.9 % of respondents ages 18-64) and dia-
betes (17.6 % of men and 15.9 % of women) [3]. As a com-
parison, the prevalence of hypertension across the UK
adult population age 20–59 is around 15.0 % [5] and the
prevalence of diabetes at all ages is 6.0 % [6]. Overall, in
Qatar, chronic diseases such as cardiovascular diseases,
diabetes, and cancer were estimated to account for 69 %
of all deaths in 2008 [7].
Chronic diseases are caused by the complex interplay
between environmental factors (such as diet, lifestyle,
and the built environment) and genetic predisposition.
To understand the aetiological role of environmental,
behavioural, and genetic factors and their interactions,
large-scale population cohorts have been established,
mainly in Europe, North America, China, Japan, and
Korea [8–16]. No such large population based studies
currently exist in the Gulf Region. The Qatar Biobank
was set up by the Qatar Foundation and the Supreme
Council of Health in collaboration with Imperial College
London, as the first Qatar national population based
prospective cohort study, and includes the collection of
biological samples, with long-term storage of data and
samples for future research (biobank). Up to 60,000 men
and women Qatari nationals and long-term residents
(defined as individuals living in Qatar for 15 years and
over) will be recruited into the cohort over the coming
years, with extensive baseline clinical, metabolic and be-
havioural phenotypic data, and blood, urine, and saliva
samples collected and stored. The Qatar Biobank will
thus provide a powerful resource to investigate the role
of environmental factors, lifestyle factors, genetics and
their interactions in subsequent disease occurrence. As
well as studying the causes of diseases, the Qatar Bio-
bank will also provide insights into the current and
future public health burden that faces the country.
Here we describe the design and methods of the Qatar
Biobank study. The questionnaires, clinical measurements,
biological sampling protocols and Standard Operating
Procedures (SOPs) were developed during pre-plot testing
and a pilot study, and we also provide here demographic
and clinical referral information for the 1209 pilot study
participants.
Methods
The Qatar Biobank involves collection of extensive ques-
tionnaire information, clinical phenotyping and bio-
logical samples from Qatari nationals and long-term
residents (≥15 years living in Qatar) aged 18 or more
years, who comprise the eligible population. A compu-
terised clinic based system was developed for the pilot
study to facilitate data collection, tracking of the partici-
pant data (and linked samples) throughout the visit and
digital download from the clinical devices to minimise
manual data entry. A summary of the data collected in
the pilot study and for the full study (including follow-
up) is shown in Fig. 1.
Recruitment into the pilot study
For the full study, it is intended that participants will be
broadly representative of the eligible Qatari population.
However, for the pilot study, recruitment focused ini-
tially on selected occupational groups and word of
mouth to provide a ready means to test the study proto-
cols and SOPs. Recruitment to the pilot was initiated on
the 11th December 2012 and we report on data collected
to 20th February 2014.
For the pilot study, initially potential participants were
contacted via a small number of public and private em-
ployers by setting up information booths at their work-
place. Subsequently, most participants were recruited by
personal recommendations of friends and family. At
baseline, participants were invited to a visit at the Qatar
Biobank facility at Hamad Medical City where they
underwent a 5-stage interview and physical and clinic
measurement sequence, with an average duration of
179 min (Fig. 2; Table 1). All participants gave informed
consent. Institutional Review Board approval was ob-
tained from the Hamad Medical Corporation Ethics
Committee.
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Self-completed health and lifestyle questionnaire
The design of the Qatar Biobank health and lifestyle
questionnaire was informed by pre-pilot testing phases
among Qatari volunteers, who provided information
about the feasibility and acceptability of different ver-
sions of the questionnaire. The computer administered
health and lifestyle section of the questionnaire contains
detailed questions on socio-demographic factors, current
and past health, family history of health conditions,
current and past smoking habits (cigarettes and water
pipe or shisha), occupational information, mobile phone
use, physical activity levels, sleeping patterns, reproduct-
ive health (women), and cognitive and psychological
state. Collection of information on cultural and lifestyle
characteristics of the Qatari population for the pilot
study was based on adaptation of widely used and vali-
dated instruments including from the European Pro-
spective Investigation into Cancer and Nutrition (EPIC)
study (smoking history, female reproductive history) [9],
UK Biobank (e.g. sleep pattern questions) [10, 11], COS-
MOS (mobile phone use) [17, 18], the Patient Health
Questionnaire (PHQ-9) (depression) [19], and the short-
ened form of the International Physical Activity Question-
naire (IPAQ) [20], which was augmented by questions on
inactivity. In response to pre-pilot testing feedback, the
health and lifestyle questions presented on the computer
screen were tailored to the participant’s age, gender, and
marital status. Similarly, a question skip pattern was ap-
plied to conditional questions as appropriate (e.g. non-
smokers were not asked smoking history questions) and
various logic and consistency checks were built into the
software to reduce error rates. A trained nurse was avail-
able for participant assistance upon request.
Dietary assessment
In the absence of an established questionnaire for assess-
ment of diet in Qatar, the instrument used in Qatar Bio-
bank was developed based on field assessment of the local
food environment, focus groups, and consultation with
local nutrition researchers. The computer-administered
diet questionnaire assessed the intake of 96 food and bev-
erage items, with either five or six frequency options
Fig. 1 A summary of the data collected in the Qatar Biobank pilot and full study (including follow-up)
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Table 1 Measurements in the Qatar Biobank pilot study
Measurement category Instrument detail
Questionnaires and cognitive function
Heath and lifestyle questionnaire Questions on socio-demographic factors, current and past health conditions, current and past
smoking habits (tobacco and shisha), occupation, mobile phone use, activity levels, sleeping
patterns, and cognitive and psychological state
Diet questionnaire Any past modifications to their diet and how often they consumed various foods and beverages
over the preceding year
Nurse interview questionnaire Previous or prevalent health conditions they or their family members may have suffered from;
information on over-the-counter and prescription medications used and, in women only,
reproductive factors
Cognitive function Paired-associated learning questions to assess global cognition.
Reaction time tests for touch screen administration
Physical and clinical measurements
Anthropometry and body composition Height, weight, waist circumference, and hip circumference
Bioimpedance analysis (Tanita)
Full body dual energy X-ray absorptiometry (iDXA) (GE) scan
Bone health Full body dual energy X-ray absorptiometry (iDXA) (GE) scan
Grip strength Grip strength using a Jamar J00105 hydraulic hand dynamometer
Retinal and disk imaging Microscopic features of the optic nerve and macula assessed by using a Topcon TRC-NW6S retinal camera
Cardiovascular system Blood pressure using the Omron 705 automated device (measured twice, or three times if first and second
measurements differed by ≥5 mm Hg)
Electrocardiogram (ECG) using the Atria 6100 automated system
Arterial stiffness as assessed by VICORDER device
3D carotid ultrasound using a Philips ultrasound system and mechano‐transducer probe
Respiratory function The Pneumotrac Vitalograph spirometry test
Cardiorespiratory fitness Treadmill sub-maximal fitness test with heart rate monitoring
Biological samples
Biological samples collected Blood, urine, and saliva
Fig. 2 Summary of the Qatar Biobank pilot study baseline visit
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depending on the nature of the item. The diet question-
naire also incorporated general questions on dietary
habits, including reasons for recent dietary modification
(if applicable), frequency of eating from a common plate,
and snacking between meals. In order to assess the in-
ternal validity of the questionnaire, general questions on
frequency of consuming broad categories of foods
(chicken, meat, fish, fast and take-away foods, snacks,
salads) were examined in relation to the sum of individual
items within the broader categories (e.g. all fast food
items), with Spearman’s rank correlations ranging from
0.30 (for sweet and savoury snacks) to 0.74 (for fish
consumption).
Cognitive function tests
Computer based self-administered tests were completed
to assess cognitive function, specifically a choice reaction
time test and a paired episodic memory test [21].
Nurse administered interview questionnaire
In a face-to-face interview, administered by a trained
nurse, participants were asked to report any previous or
prevalent health conditions they or their family members
may have suffered from; plus information on over-the-
Table 2 The 66 clinical biomarkers routinely measured in the
Qatar Biobank pilot study
Group Variable
Bone and joint markers Calcium
Phosphorus
Uric acid
Vitamin D
Coagulation tests Activated partial thromboplastin time
Fibrinogen level
International normalized ratio
Prothrombin time
Diabetes related tests C-Peptide
Glucose
Glycated Haemoglobin A1c %
Insulin
Differential white cell count Basophil
Basophil %
Eosinophils
Eosinophils %
Lymphocytes
Lymphocytes %
Monocyte
Monocyte %
Neutrophils
Neutrophils %
White blood cell
Electrolytes and renal
function tests
Chloride
Serum creatinine
Bicarbonate
Potassium
Sodium
Urea nitrogen
Full blood count Haematocrit
Haemoglobin
Mean corpuscular haemoglobin
Mean corpuscular HGB concentration
Mean corpuscular volume
Mean platelet volume
Platelets
Red blood cell
Sex steroid hormones Estradiol
Sex hormone binding globulin
Testosterone
Inflammation/Autoimmune Rheumatoid factor
C-Reactive protein
Lipid profile Cholesterol
Table 2 The 66 clinical biomarkers routinely measured in the
Qatar Biobank pilot study (Continued)
High density lipoprotein
Low density lipoprotein
Triglycerides
Liver function tests Albumin
Alkaline phosphatase
Alanine transaminase
Aspartate transaminase
Gamma glutamyl transferase
Total bilirubin
Total protein
Minerals Iron
Ferritin
Magnesium
Total Iron binding capacity
Muscle markers Creatine kinase
Myoglobin
Thyroid function tests Free triiodothyronine
Free thyroxine
Thyroid stimulating hormone
Vitamins Vitamin B12
Folate serum
Other tests Homocysteine
N-terminal brain-type natriuretic peptide
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counter and prescription medication use and reproduct-
ive history (women only).
Physical and clinical measurements
Various physical measurements were collected from each
participant. Anthropometric measurements comprised
body weight, height (sitting and standing) using the Seca
stadiometer, hip and waist circumferences as well as
bioimpedance (Tanita). To assess muscle strength, grip
strength was measured in the participants’ right and left
hands using a hydraulic hand dynamometer (Jamar
J00105) [22]. Participants had an electrocardiogram (ECG)
using the Atria 6100 automated system [23]. Arterial stiff-
ness was assessed by the VICORDER device [24]. For
blood pressure, using the Omron 705 automated device
[25], two diastolic and systolic blood pressure measure-
ments were obtained, and if these differed by 5 mmHg or
more, a third measurement was made. Respiratory func-
tion was assessed by spirometry using the Pneumotrac
Vitalograph [26].
Several imaging technologies were used. These in-
cluded: 3D carotid ultrasound to measure intima media
thickness (IMT) and carotid plaques using a Philips
ultrasound system and mechano‐transducer probe [27];
full body dual energy X-ray absorptiometry (iDXA; Gen-
eral Electric) scan to assess bone mineral density and
body composition [28]; and “microscopic” features of the
optic nerve and macula assessed by use of a Topcon
TRC-NW6S retinal camera [29]. Cardiorespiratory fit-
ness was tested by a graded treadmill test of 5 to 11 min
duration (dependent on self-rated fitness) using the h/p/
cosmos quasar device [30]. For the full study, magnetic
resonance imaging (MRI) of the brain, heart and abdo-
men is planned among a sub-sample of participants.
Biological material collected
During the baseline recruitment visit, pilot participants
provided samples of blood, saliva and urine. Approxi-
mately 60 ml of blood was collected from each participant.
A proportion of the blood was used for the measurement
of the 66 clinical biomarkers routinely measured (Table 2).
Haematology and blood biochemistry were analysed by
the laboratories of the Hamad Medical Centre Laboratory,
Doha. The remainder, plus the urine and saliva, was subdi-
vided into a number of aliquots, and then transferred into
2 dimensional barcode labelled microtubes for long-term
cryogenic storage. A participant’s sample aliquots were
split for storage in two separate locations—one for active
use stored at −80 °C and one as a long-term backup (in
liquid nitrogen vapour phase for the full study). The
EDTA blood samples were centrifuged to separate blood
into its constituent components, in the form of layers:
plasma, buffy coat (leucocytes) and erythrocytes.
Results
Age of the 1209 participants recruited in the pilot study
ranged between 25 and 80 years, with a median age of
39 years; 42 % were men, 58 % women (Fig. 3). The ma-
jority of participants were Qatari nationals (74 %) and
19 % were long-term residents of Arabic origin; the
remaining 6 % were long-term residents of non-Arabic
origin. Approximately two-thirds of men (67.6 %) and
Fig. 3 Age distribution of men and women recruited into the Qatar Biobank pilot study (N = 1209, mean = 39.89 years, SD = 12.92; median = 39 years)
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women (64.1 %) in the pilot study were educated to uni-
versity graduate level and above (Table 3). Paid employee
was the most common employment status for both men
(74.5 %) and women (45.5 %).
Clinical referrals were made for participants with
out of range values of clinical data, based on review
by a doctor or a nurse. During the pilot study, 520 of
the 1209 participants (43 %) were clinically referred.
Most of these referrals were made for diabetes related
tests (N = 198 participants; 16.3 %), low forced expira-
tory volume in one second based on spirometry (pre-
dicted FEV1 less than 80 % based on the best
spirometry attempt, N = 173; 14.3 %), and indications
of poor bone health based on iDXA scan measurement of
bone density and low vitamin D levels (N = 160; 13.2 %).
Discussion
The Qatar Biobank offers an unprecedented opportunity
to study the causes and public health burden of diseases
affecting the Qatari population which has undergone a
major health transition over the past 50 years. It is col-
lecting a broad range of phenotypic data. These include
data from questionnaires, extensive clinical measure-
ments and imaging, and biological samples (blood, urine,
and saliva), which are being stored long-term, with
consent, for future (unspecified) research use includ-
ing for genetic studies. The pilot study was well
accepted with high satisfaction levels reported by par-
ticipants; 94 % (N = 1136) reported that if given the
opportunity they would take part again. Following
completion of the pilot, the study is now entering a
phase of progressive increase in the number of partic-
ipants attending the baseline visit, with recruitment
widened to capture a sample designed to be as repre-
sentative as possible of the eligible Qatari population, aim-
ing for a total sample size of up to 60,000 individuals. A
dedicated high-specification building has been assigned to
the Qatar Biobank, including a clinic facility, laboratory,
liquid nitrogen storage facility, offices for clinic and re-
search staff, and an MRI suite. Data collection for the full
study is planned over the next several years to achieve the
projected sample size.
Already, the Qatar Biobank is having an impact on the
health of participants due to the rigorous system of clin-
ical referrals based on out of range values from the ex-
tensive clinical phenotypic information collected.
Clinical measurements and biochemical data are fed
back to participants by a doctor or nurse and clinical re-
ferrals (with consent) are made as necessary. Clinical re-
ferrals following face-to-face feedback of results to
participants 3 to 6 weeks after their initial visit are an
important and unique feature of the Qatar Biobank; such
referrals have not been included in the protocol of most
large-scale population based prospective studies. The
feedback from study participants indicates that this
process is highly valued. There was a high proportion of
participants who were clinically referred in the pilot
study, reflecting high prevalence of chronic conditions
such as diabetes, low bone density and Vitamin D defi-
ciency. The referral criteria for the extensive clinical
phenotypic information collected are being further evalu-
ated to optimise sensitivity and specificity of the referral
procedure.
The Qatar Biobank will be a unique resource with
large numbers of the eligible population enrolled. Add-
itionally, the breadth and depth of phenotypic informa-
tion and biological samples collected from participants is
Table 3 Baseline socio-demographic characteristics of participants
in the Qatar Biobank pilot study (December 2012-February 2014
(N = 1209))
Characteristic Men Women
N (%) N (%) P-value
Age group (years) 0.15
< 25 54 (10.7) 94 (13.4)
25–34 145 (28.7) 212 (30.2)
35–44 102 (20.2) 127 (18.1)
45–54 118 (23.3) 179 (25.5)
≥ 55 87 (17.2) 91 (12.9)
Marital status <0.001
Married 402 (79.5) 461 (65.6)
Divorced/separated 14 (2.7) 33 (4.7)
Widow/widower 1 (0.2) 23 (3.3)
Single 89 (17.6) 186 (26.4)
Education <0.001
Less than primary school 1 (0.2) 28 (3.9)
Primary school 10 (2.0) 30 (4.3)
Secondary school 36 (7.1) 37 (5.3)
Technical/professional school 116 (22.9) 155 (22.1)
University 270 (53.4) 408 (58.0)
Postgraduate degree 72 (14.2) 43 (6.1)
Missing 1 (0.2) 2 (0.3)
Employment status <0.001
Student or trainee 32 (6.3) 70 (10.0)
Paid employee 377 (74.5) 320 (45.5)
Self-employed/business owner 49 (9.7) 9 (1.3)
Housewife 0 (0) 189 (26.9)
Retired 22 (4.3) 80 (11.4)
Unemployed 8 (1.6) 15 (2.1)
None of the above 8 (1.6) 19 (2.7)
Prefer not to answer 9 (1.8) 1 (0.1)
Missing 1 (0.2) 0 (0)
P-values for sex comparison calculated using Chi-squared test
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unparalleled by any other study in the Middle East and
Asia. The imaging modules will be further augmented in
the full study when a sub-sample of participants will
undergo MRI scans of the brain, heart and abdomen.
Again to our knowledge, such a comprehensive and
state-of-the-art imaging protocol has not been imple-
mented in large-scale population cohorts in the Middle
East and Asia.
Participants will be followed up long-term through
data linkage to clinical records (with consent) and oc-
currences of health related outcomes will be recorded.
Furthermore, it is planned that participants will be re-
contacted actively in the future for the collection of repeat
phenotypic and medical condition information.
Conclusion
The Qatar Biobank is a major new prospective cohort
study in the Gulf region, with extensive data collection
and storage of biological samples and linkage to health
records for follow up. This will provide unprecedented
opportunity to study the future health and disease bur-
den as they evolve over the coming years among the
Qatari population.
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